FDA Import Refusal UPS-5963341-3/11/1 — Sanofi
The FDA refused shipment UPS-5963341-3/11/1 from Sanofi (Canada) on Nov 17, 2017. The refused product falls under Drugs and Biologics — INSULIN (INJ) (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Nov 17, 2017
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY17 INSULIN (INJ) (ANTI-DIABETIC)
- Charges
- 75